Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Shares Issued (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Shares Issued data on record, last reported at $1.9 million in Q4 2025.

  • For Q4 2025, Shares Issued rose 118.52% year-over-year to $1.9 million; the TTM value through Dec 2025 reached $2.5 million, down 94.97%, while the annual FY2025 figure was $2.5 million, 94.97% down from the prior year.
  • Shares Issued reached $1.9 million in Q4 2025 per PLSE's latest filing, up from -$13.5 million in the prior quarter.
  • Across five years, Shares Issued topped out at $59.6 million in Q3 2024 and bottomed at -$55.9 million in Q4 2021.
  • Average Shares Issued over 5 years is $3.6 million, with a median of $321500.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: tumbled 24730.4% in 2021, then skyrocketed 152444.44% in 2025.
  • A 5-year view of Shares Issued shows it stood at -$55.9 million in 2021, then surged by 99.13% to -$485000.0 in 2022, then surged by 3081.65% to $14.5 million in 2023, then plummeted by 170.71% to -$10.2 million in 2024, then soared by 118.52% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $1.9 million in Q4 2025, -$13.5 million in Q3 2025, and $13.7 million in Q2 2025.